Personalised prescribing for asthma--is pharmacogenetics the answer?
about
Maximum Time of the Effect of Antileukotriene - Zileuton in Treatment of Patients with Bronchial Asthma.Comparison of Glucocorticoid (Budesonide) and Antileukotriene (Montelukast) Effect in Patients with Bronchial Asthma Determined with Body Plethysmography.Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.
P2860
Personalised prescribing for asthma--is pharmacogenetics the answer?
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Personalised prescribing for asthma--is pharmacogenetics the answer?
@ast
Personalised prescribing for asthma--is pharmacogenetics the answer?
@en
type
label
Personalised prescribing for asthma--is pharmacogenetics the answer?
@ast
Personalised prescribing for asthma--is pharmacogenetics the answer?
@en
prefLabel
Personalised prescribing for asthma--is pharmacogenetics the answer?
@ast
Personalised prescribing for asthma--is pharmacogenetics the answer?
@en
P2860
P356
P1476
Personalised prescribing for asthma--is pharmacogenetics the answer?
@en
P2093
Jane C Dewar
P2860
P304
P356
10.1211/0022357021080
P50
P577
2003-03-01T00:00:00Z